Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

OTHER 45 INDUSTRY 5 OTHER_GOV 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymus Neoplasms 1 Thymoma 1 Cardiotoxicity 1

Interventions

Radiotherapy 10 Early Intervention, Educational 7 Standard of Care 6 Magnetic Resonance Spectroscopy 6 Interviews as Topic 6 Educational Status 6 Radiotherapy, Conformal 5 Practice Guidelines as Topic 5 Methods 5 Cyclophosphamide 5 Vincristine 4 Psychiatric Rehabilitation 4 Cisplatin 4 Brachytherapy 4 Biopsy 4 Surgical Procedures, Operative 3 Specimen Handling 3 Radiosurgery 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Dexamethasone 3 Counseling 3 Carboplatin 3 pegaspargase 2 motexafin gadolinium 2 etoposide phosphate 2 Radiofrequency Ablation 2 Radiation 2 Preoperative Exercise 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NETWORK × Proton Therapy × Clear all

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡